title: Prescribing in Parkinson's disease: a story of hope and adverse events.
abstract: A review of National Health Service spending in England on prescription drugs used in Parkinsonism over the last 10 years shows that spending has risen rapidly and that newly introduced drugs are quickly and expensively adopted. This paper explores the gains and costs of such prescribing.
authors.affiliation: Department of Neurology, Gloucestershire Hospitals NHS, Beacon House, Great Western Road, Gloucester GL1 3NN, UK. paul.morrish@glos.nhs.uk
authors.forename: Paul
authors.initials: P
authors.lastname: Morrish
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D055553:Prescription Drugs / Q000009:adverse effects*
chemical_list: D000978:Antiparkinson Agents; D055553:Prescription Drugs